IDH2 and neoplasm: First, we found that mice inoculated with the same number of MB-231 tumor cells showed a significant volume of subcutaneous tumor tissue in the NC group at 7 days, whereas mice in the shRNA-IDH2 group had significantly smaller subcutaneous tumors, which were approximately 60% of the subcutaneous tumors in the NC group (Fig. 5B).